Unknown

Dataset Information

0

Emerging role of 18F-FDG PET/CT in Castleman disease: a review.


ABSTRACT: Castleman disease (CD) describes a group of rare hematologic conditions involving lymphadenopathy with characteristic histopathology and a spectrum of clinical abnormalities. CD is divided into localized or unicentric CD (UCD) and multicentric CD (MCD) by imaging. MCD is further divided based on etiological driver into human herpesvirus-8-associated MCD, POEMS-associated MCD, and idiopathic MCD. There is notable heterogeneity across MCD, but increased level of pro-inflammatory cytokines, particularly interleukin-6, is an established disease driver in a portion of patients. FDG-PET/CT can help determine UCD versus MCD, evaluate for neoplastic conditions that can mimic MCD clinico-pathologically, and monitor therapy responses. CD requires more robust characterization, earlier diagnosis, and an accurate tool for both monitoring and treatment response evaluation; FDG-PET/CT is particularly suited for this. Moving forward, future prospective studies should further characterize the use of FDG-PET/CT in CD and specifically explore the utility of global disease assessment and dual time point imaging.Trial registration ClinicalTrials.gov, NCT02817997, Registered 29 June 2016, https://clinicaltrials.gov/ct2/show/NCT02817997.

SUBMITTER: Koa B 

PROVIDER: S-EPMC7952491 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8943998 | biostudies-literature
| S-EPMC9206060 | biostudies-literature
| S-EPMC8833535 | biostudies-literature
| S-EPMC5221689 | biostudies-other
| S-EPMC7394511 | biostudies-literature
| S-EPMC8803713 | biostudies-literature
| S-EPMC10746864 | biostudies-literature
| S-EPMC6105570 | biostudies-literature
| S-EPMC8625716 | biostudies-literature
| S-EPMC8177955 | biostudies-literature